Evidence map›Paper›PMID 32753145›Full record

ReviewMayo Clinic proceedings2020

Sex Hormones and Novel Corona Virus Infectious Disease (COVID-19).

Rasha A Al-Lami, Randall J Urban, Elena Volpi, Ammar M A Algburi, Jacques Baillargeon

Open access · bronzeAbstract readReview
In one paragraph

Review in Mayo Clinic proceedings, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 1 pooled it
13.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 1 synthesis or guideline pooled it, 139 citations in OpenAlex.

  1. Pooled it
  2. Androgens are a Key Factor Affecting Immune Related Diseases.The world journal of men's health · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. A review of the role of testosterone in the care of the critically ill patient.The Southern African journal of critical care : the official journal of the Critical Care Society · 2024
    Review
  8. Article
  9. Article
  10. The Impact of COVID-19 on Menstrual Cycle in Women.Journal of clinical medicine · 2023
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Small molecules in the treatment of COVID-19.Signal transduction and targeted therapy · 2022
    Review
  19. Article
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Rasha A Al-LamiDepartment of Preventive Medicine and Population Health, University of Texas Medical Branch, Galveston. Electronic address: raallami@utmb.edu.
Randall J UrbanDepartment of Internal Medicine, University of Texas Medical Branch, Galveston.
Elena VolpiDepartment of Internal Medicine, University of Texas Medical Branch, Galveston.
Ammar M A AlgburiAl-Yarmouk Teaching Hospital, Baghdad, Iraq.
Jacques BaillargeonDepartment of Preventive Medicine and Population Health, University of Texas Medical Branch, Galveston.
The University of Texas Medical Branch at Galveston · USAl Yarmouk University College · IQ

Funding

UTMB Clinical and Translational Science AwardUL1TR001439 · NCATS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI URBAN, RANDALL J · 2015 to 2024
$40.0M
UTMB OAIC Research Education Component (REC)P30AG024832 · NIA · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI JAMES S. GOODWIN, MD, MELISSA M. MORROW · 2005 to 2026
$26.7M
NCATS NIH HHS UL1 TR001439NIA NIH HHS P30 AG024832
6 · The paper itself

Abstract

Given the rapid spread of the coronavirus disease 2019 (COVID-19) pandemic and its overwhelming effect on health care systems and the global economy, innovative therapeutic strategies are urgently needed. The proposed primary culprit of COVID-19 is the intense inflammatory response-an augmented immune response and cytokine storm-severely damaging the lung tissue and rendering some patients' conditions severe enough to require assisted ventilation. Sex differences in the response to inflammation have been documented and can be attributed, at least in part, to sex steroid hormones. Moreover, age-associated decreases in sex steroid hormones, namely, estrogen and testosterone, may mediate proinflammatory increases in older adults that could increase their risk of COVID-19 adverse outcomes. Sex hormones can mitigate the inflammation response and might provide promising therapeutic potential for patients with COVID-19. In this article, we explore the possible anti-inflammatory effects of estrogen and testosterone and the anabolic effect of testosterone, with particular attention to the potential therapeutic role of hormone replacement therapy in older men and women with COVID-19.

Indexed as

BetacoronavirusAgedAged, 80 and overAge FactorsAnti-Inflammatory AgentsCoronavirus InfectionsCOVID-19EstrogensFemaleHormone Replacement TherapyHumansInflammationMalePandemicsPneumonia, ViralSARS-CoV-2Anti-Inflammatory AgentsEstrogensTestosterone

Identifiers

PMID32753145
PMCPMC7256539
OpenAlexW3029315012

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.